Full Sail Capital, LLC Novo Nordisk A S Transaction History

Full Sail Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$132.34 - $159.14 $168,204 - $202,266	1,271 New	1,271 $202,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $460,478 - $507,690	-7,230 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $409 - $475	-7 Reduced 0.1%	7,230 $473,000
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $7,320 - $9,587	-148 Reduced 2.0%	7,237 $454,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $4,287 - $5,010	-86 Reduced 1.15%	7,385 $468,000
Q3 2019 Nov 20, 2019	BUY	$47.54 - $53.43 $760 - $854	16 Added 0.21%	7,471 $430,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $12,586 - $14,114	-269 Reduced 3.48%	7,455 $375,000
Q1 2019 May 16, 2019	BUY	$46.36 - $52.63 $358,084 - $406,514	7,724 New	7,724 $404,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Full Sail Capital, LLC with notifications on news.